ClinicalTrialsFinder

Recurrent or Refractory IgG4 Related Diseases Clinical Trials in Wuhan, Hubei

1 recruitingWuhan, Hubei, China

Showing 1–1 of 1 trials

Recruiting
Early Phase 1

the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases

Recurrent or Refractory Systemic Lupus ErythematosusRecurrent or Refractory IgG4 Related DiseasesRecurrent or Refractory Systemic Sclerosis+2 more
Tongji Hospital45 enrolled1 locationNCT07339540